Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ARDMQ OTCMKTS:MAGAA OTCMKTS:NIMU OTCMKTS:NXNN OTCMKTS:RSLSD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARDMQAradigm$0.05$0.05$0.02▼$0.20$764KN/A21,923 shsN/AMAGAAMagna-Lab$0.07$0.08$0.11▼$2.00$87K7.513,117 shsN/ANIMUNon-Invasive Monitoring Systems$0.00$0.01$0.00▼$0.02$635K0.974,069 shsN/ANXNNNexeon Medsystems$0.00$0.00▼$0.00N/A6.98300 shs200 shsRSLSDReShape Lifesciences$0.00$2.91▼$82.80$1.90M2.031,362 shs6,500 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARDMQAradigm0.00%0.00%0.00%0.00%0.00%MAGAAMagna-Lab0.00%0.00%-2.12%+39.62%-34.57%NIMUNon-Invasive Monitoring Systems0.00%0.00%-54.44%-54.44%-79.29%NXNNNexeon Medsystems0.00%0.00%0.00%0.00%0.00%RSLSDReShape Lifesciences0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationARDMQAradigmN/AN/AN/AN/AN/AN/AN/AN/AMAGAAMagna-LabN/AN/AN/AN/AN/AN/AN/AN/ANIMUNon-Invasive Monitoring SystemsN/AN/AN/AN/AN/AN/AN/AN/ANXNNNexeon MedsystemsN/AN/AN/AN/AN/AN/AN/AN/ARSLSDReShape LifesciencesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARDMQAradigm 0.00N/AN/AN/AMAGAAMagna-Lab 0.00N/AN/AN/ANIMUNon-Invasive Monitoring Systems 0.00N/AN/AN/ANXNNNexeon Medsystems 0.00N/AN/AN/ARSLSDReShape Lifesciences 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARDMQAradigmN/AN/AN/AN/AN/AN/AMAGAAMagna-LabN/AN/AN/AN/A($1.52) per shareN/ANIMUNon-Invasive Monitoring SystemsN/AN/AN/AN/AN/AN/ANXNNNexeon MedsystemsN/AN/AN/AN/AN/AN/ARSLSDReShape Lifesciences$610K0.00N/A0.08$341.84 per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARDMQAradigmN/AN/A0.00∞N/AN/AN/AN/AN/AMAGAAMagna-Lab-$130K$0.180.41∞N/AN/A-12.32%42,399.99%N/ANIMUNon-Invasive Monitoring Systems-$110KN/A0.00∞N/AN/AN/A-251.43%N/ANXNNNexeon MedsystemsN/AN/A0.00N/AN/AN/AN/AN/AN/ARSLSDReShape Lifesciences-$81.15MN/A0.00N/AN/A-668.58%-163.22%-52.10%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARDMQAradigmN/AN/AN/AN/AN/AMAGAAMagna-LabN/AN/AN/AN/AN/ANIMUNon-Invasive Monitoring SystemsN/AN/AN/AN/AN/ANXNNNexeon MedsystemsN/AN/AN/AN/AN/ARSLSDReShape LifesciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARDMQAradigmN/AN/AN/AMAGAAMagna-LabN/AN/AN/ANIMUNon-Invasive Monitoring SystemsN/A0.030.03NXNNNexeon MedsystemsN/AN/AN/ARSLSDReShape Lifesciences0.051.171.07Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARDMQAradigmN/AMAGAAMagna-LabN/ANIMUNon-Invasive Monitoring Systems0.12%NXNNNexeon MedsystemsN/ARSLSDReShape LifesciencesN/AInsider OwnershipCompanyInsider OwnershipARDMQAradigm4.50%MAGAAMagna-Lab15.30%NIMUNon-Invasive Monitoring Systems28.80%NXNNNexeon Medsystems61.19%RSLSDReShape LifesciencesN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARDMQAradigm2315.28 millionN/ANot OptionableMAGAAMagna-Lab201.18 millionN/ANot OptionableNIMUNon-Invasive Monitoring Systems3154.81 million110.23 millionNot OptionableNXNNNexeon Medsystems60N/AN/ANot OptionableRSLSDReShape Lifesciences50354,000N/ANot OptionableRSLSD, NIMU, NXNN, ARDMQ, and MAGAA HeadlinesRecent News About These CompaniesInsider Selling: STANKOVICH THOMAS, ReShape Lifesciences Inc. [RSLS] Chief Financial Officer divested 106 sharesNovember 2, 2023 | knoxdaily.comKReShape Lifesciences (NASDAQ: RSLS) up 60% - But why in the name of….?October 27, 2023 | dhakatribune.comDReShape Lifesciences Inc. [RSLS] Shares Fall Approximately -98.23% Over the YearOctober 12, 2023 | knoxdaily.comKReShape Lifesciences Inc: ReShape Lifesciences Signs Exclusive License Agreement With Biorad Medisys for Obalon Gastric Balloon SystemSeptember 21, 2023 | finanznachrichten.deReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon SystemSeptember 21, 2023 | finance.yahoo.comRecent Insider Activity Could Benefit ReShape Lifesciences Inc. (RSLS)June 29, 2023 | knoxdaily.comKReShape Lifesciences® Submits FDA PMA Supplement Application for the Next-Generation Lap-Band® 2.0June 26, 2023 | finance.yahoo.comPotential Price Increase for ReShape Lifesciences Inc. (RSLS) After Recent Insider ActivityJune 19, 2023 | knoxdaily.comKReShape Lifesciences® to Participate in Investor and Industry Conferences in JuneJune 14, 2023 | finance.yahoo.comReShape Lifesciences Inc. (NASDAQ:RSLS) Q1 2023 Earnings Call TranscriptMay 17, 2023 | insidermonkey.comReShape Lifesciences® to Present Data on its Proprietary Diabetes Bloc-Stim Neuromodulation™ Device at the Keystone Symposia on Type 2 DiabetesApril 27, 2023 | markets.buffalonews.comMReShape Lifesciences Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-MarketApril 20, 2023 | finance.yahoo.comReShape Lifesciences(R) Receives Notice of Allowance for U.S. Patent Related to its Obalon(R) Balloon SystemApril 12, 2023 | marketwatch.comReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to its Obalon® Balloon SystemApril 11, 2023 | finance.yahoo.comReShape Lifesciences postpones earnings releaseMarch 31, 2023 | seekingalpha.comEarnings Outlook For Reshape LifesciencesMarch 28, 2023 | msn.comReShape Lifesciences Announces Closing of Upsized $10.2 Million Underwritten Public OfferingFebruary 8, 2023 | benzinga.comWhy Is Reshape Lifesciences (RSLS) Stock Up 136% Today?February 3, 2023 | msn.comReShape Lifesciences Inc. (RSLS) Q3 2022 Earnings Call TranscriptNovember 14, 2022 | seekingalpha.comReShape Lifesciences™ Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNovember 14, 2022 | yahoo.comRSLSD, NIMU, NXNN, ARDMQ, and MAGAA Company DescriptionsAradigm OTCMKTS:ARDMQ$0.05 0.00 (0.00%) As of 06/30/2020Aradigm Corp. is a leading developer of advanced pulmonary drug delivery systems for the treatment of systemic conditions as well as lung diseases. Their hand-held AERx platform is being designed for the rapid and reproducible delivery of a wide range of pharmaceutical drugs and biotech compounds via the lung.Magna-Lab OTCMKTS:MAGAA$0.07 0.00 (0.00%) As of 07/11/2025Magna-Lab Inc. does not have significant operations. It intends to identify and merge with an operating company. Previously, the company was engaged in the research, development, and commercialization of disposable medical devices to enhance the effectiveness of magnetic resonance imaging in detection and diagnosis of heart disease. The company was founded in 1991 and is based in Plainview, New York. Magna-Lab Inc. is a subsidiary of Magna Acquisition LLC.Non-Invasive Monitoring Systems OTCMKTS:NIMU$0.0041 0.00 (0.00%) As of 07/11/2025Non-Invasive Monitoring Systems, Inc. does not have significant operations. Previously, it was involved in the research, development, manufacture, marketing, and sale of non-invasive, motorized, and whole body periodic acceleration platforms. The company was incorporated in 1980 and is based in Miami, Florida.Nexeon Medsystems OTCMKTS:NXNNNexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.ReShape Lifesciences OTCMKTS:RSLSDReShape Lifesciences Inc., a medical device company, focuses on the design, development, and commercialization of technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. The company's product portfolio includes ReShape vBloc, a therapy that enables patients to feel full and eat less by intermittently blocking hunger signals on the vagus nerve; ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without permanently changing patient anatomy; and Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in San Clemente, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Insider Selling Hits Market Leaders—Should You Be Worried? MP Materials Stock Booms on New Government Positioning MarketBeat Week in Review – 07/07 - 07/11 How Texas Roadhouse Is Winning in a Changing Consumer Market Power Solutions International Poised for 75% Upside The Meteoric Rise of Rocket Lab: A Space Stock to Watch Meta and Autonomous Advertising: The Stock's Next Big Tailwind? 3 Catalysts Converge on Intel Ahead of a Critical Earnings Report Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
